Asymptomatic neuropathy seen early in Crohn's disease | Neurology
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Communities Neuro Asymptomatic neuropathy seen early in Crohn's disease

Asymptomatic neuropathy seen early in Crohn's disease

Specialties - Neurology

Subclinical sympathetic neuropathy develops early in the course of Crohn's disease, investigators in Sweden report.

Subclinical sympathetic neuropathy develops early in the course of Crohn's disease, investigators in Sweden report.

"We think that the sympathetic neuropathy may be evidence that inflammatory bowel disease is a general disease involving a great part of the body, and not only the bowel," Dr. Bodil Ohlsson from Lund University, Malmo, told Reuters Health.

Dr. Ohlsson and associates compared autonomic nerve function in controls and patients with short-duration Crohn's disease at baseline and seven years later to determine whether neuropathy is a concomitant manifestation of the disease or a complication that develops many years later.

Resting blood pressure did not differ between controls and patients with Crohn's disease, but systolic blood pressure was significantly lower eight minutes into the baseline orthostatic tilt table test in patients than in controls, the authors report in the August 14 issue of BMC Gastroenterology.

At the seven-year assessment, the systolic blood pressure one minute into the orthostatic tilt table test tended to be lower in patients than in controls and after eight minutes the difference remained significant.

These orthostatic blood pressure changes were not associated with frequent relapses, severe disease, or use of aggressive immune modulating drugs. There were no differences between Crohn's disease patients and controls in the deep breathing test and laser Doppler perfusion imaging at baseline or at the second assessment seven years later, the investigators report.

"We should be aware that patients with Crohn's disease for many years may have clinical signs of autonomic neuropathy," Dr. Ohlsson said. "Further, we should be aware that these patients may have changes in the enteric nervous system explaining dysmotility in the absence of inflammatory relapse of the mucosa."

"Not all attacks of constipation or diarrhea are signs of inflammatory relapses, but can be signs of autonomic or enteric neuropathy," Dr. Ohlsson explained. "Thus, these changes ought not be treated by anti-inflammatory drugs."

BMC Gastroenterology 2007;7:33.

 

Related Articles